Creating a tool to predict treatment outcomes for suicidal service members
Development of a Treatment Prognosis Calculator for the Prevention of Suicide
This study is testing a new tool to help figure out which military personnel struggling with suicidal thoughts will do better with regular treatment or a special therapy called Brief Cognitive Behavioral Therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT06094218 on ClinicalTrials.gov |
What this trial studies
This interventional study aims to develop and test a treatment prognosis calculator designed to identify military personnel with suicidal ideation who are likely to respond to standard care versus those who would benefit more from Brief Cognitive Behavioral Therapy (BCBT). The study will involve active duty service members engaged in mental health treatment, assessing their responses to treatment as usual (TAU) and comparing it to BCBT for those predicted to have inadequate responses to TAU. The ultimate goal is to enhance treatment effectiveness and reduce suicidal ideation among service members.
Who should consider this trial
Good fit: Ideal candidates for this study are active duty service members aged 18 and older who are currently engaged in mental health treatment and exhibit suicidal ideation.
Not a fit: Patients with psychiatric or medical conditions that prevent informed consent or participation in treatments, such as psychosis or acute intoxication, may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly improve treatment outcomes for service members experiencing suicidal thoughts by personalizing their care.
How similar studies have performed: While the approach of developing a treatment prognosis calculator is innovative, similar studies focusing on personalized treatment for suicidal ideation have shown promise in improving outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. female and male active duty service members; 2. =\> 18 years old; 3. engaged in mental health treatment at one of the sites at study enrollment; 4. score \>0 on the Columbia Suicide Severity Rating Scale (CSSRS) Screener-Recent, or indicated suicidal ideation on questions 4 or 5 of the Scale for Suicidal Ideation, indicating suicidal ideation within the last month; 5. able to understand and speak English; 6. able to provide consent. Exclusion Criteria: (1) participants with a psychiatric or medical condition that prevents them from providing informed consent or from participating in the treatments (e.g., psychosis, mania, acute intoxication).
Where this trial is running
Columbus, Ohio
- Harding Hospital — Columbus, Ohio, United States (Recruiting)
Study contacts
- Study coordinator: Jay Fournier, PhD
- Email: jay.fournier@osumc.edu
- Phone: 614-293-9889
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.